Knox SJ - Search Results

1

Radiobiology of radioimmunotherapy with 90Y ibritumomab tiuxetan (Zevalin).

Hernandez MC, Knox SJ. Hernandez MC, et al. Among authors: knox sj. Semin Oncol. 2003 Dec;30(6 Suppl 17):6-10. doi: 10.1053/j.seminoncol.2003.10.005. Semin Oncol. 2003. PMID: 14710397 Review.

2

Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam irradiation.

Knox SJ, Goris ML, Wessels BW. Knox SJ, et al. Radiother Oncol. 1992 Feb;23(2):111-7. doi: 10.1016/0167-8140(92)90342-r. Radiother Oncol. 1992. PMID: 1546186 Review.

3

Overview of studies on experimental radioimmunotherapy.

Knox SJ. Knox SJ. Cancer Res. 1995 Dec 1;55(23 Suppl):5832s-5836s. Cancer Res. 1995. PMID: 7493355 Review.

4

The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts.

Wilder RB, McGann JK, Sutherland WR, Waller EK, Minchinton AI, Goris ML, Knox SJ. Wilder RB, et al. Among authors: knox sj. Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):119-26. doi: 10.1016/0360-3016(94)90149-x. Int J Radiat Oncol Biol Phys. 1994. PMID: 8270432

5

Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.

Wilder RB, Langmuir VK, Mendonca HL, Goris ML, Knox SJ. Wilder RB, et al. Among authors: knox sj. Cancer Res. 1993 Jul 1;53(13):3022-7. Cancer Res. 1993. PMID: 8319209

6

Intratumoral radioimmunotherapy of a human colon cancer xenograft using a sustained-release gel.

Ning S, Trisler K, Brown DM, Yu NY, Kanekal S, Lundsten MJ, Knox SJ. Ning S, et al. Among authors: knox sj. Radiother Oncol. 1996 May;39(2):179-89. doi: 10.1016/0167-8140(96)01718-5. Radiother Oncol. 1996. PMID: 8735485 Free article.

7

Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.

Ning S, Trisler K, Wessels BW, Knox SJ. Ning S, et al. Among authors: knox sj. Cancer. 1997 Dec 15;80(12 Suppl):2519-28. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2519::aid-cncr26>3.3.co;2-t. Cancer. 1997. PMID: 9406705

8

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.

Knox SJ, Goris ML, Trisler K, Negrin R, Davis T, Liles TM, Grillo-López A, Chinn P, Varns C, Ning SC, Fowler S, Deb N, Becker M, Marquez C, Levy R. Knox SJ, et al. Clin Cancer Res. 1996 Mar;2(3):457-70. Clin Cancer Res. 1996. PMID: 9816191

9

Clinical radioimmunotherapy.

Knox SJ, Meredith RF. Knox SJ, et al. Semin Radiat Oncol. 2000 Apr;10(2):73-93. doi: 10.1016/s1053-4296(00)80045-4. Semin Radiat Oncol. 2000. PMID: 10727597 Review.

10

Radioimmunotherapy of B-cell NHL.

Meredith RF, Knox SJ. Meredith RF, et al. Among authors: knox sj. Curr Pharm Biotechnol. 2001 Dec;2(4):327-39. doi: 10.2174/1389201013378590. Curr Pharm Biotechnol. 2001. PMID: 11762414 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

218 results

Search Page